H 
Humana HUM · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
423.22
-2.43%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$129.66bn
FY2016FY2025
Net income
$1.19bn
FY2016FY2025
Free cash flow
$375.0m
FY2016FY2025
Shareholders' equity
$17.66bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66bn | $117.81bn | $106.44bn | $92.92bn | $83.65bn | $77.19bn | $64.93bn | $56.94bn | $53.80bn | $54.41bn |
| Gross profit | $18.85bn | $17.15bn | $18.05bn | $17.23bn | $14.45bn | $15.69bn | $11.19bn | $11.19bn | $7.08bn | $7.77bn |
| Operating income | $3.23bn | $2.38bn | $3.88bn | $3.56bn | $3.68bn | $4.96bn | $3.43bn | $3.32bn | −$1.42bn | $1.74bn |
| Net income | $1.19bn | $1.21bn | $2.49bn | $2.81bn | $2.93bn | $3.37bn | $2.71bn | $1.68bn | $2.45bn | $614.0m |
| Diluted earnings per share | 9.87 | 9.99 | 20.32 | 22.33 | 22.81 | 25.49 | 20.30 | 12.24 | 17.18 | 4.11 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $48.75bn | $46.31bn | $46.89bn | $43.73bn | $44.75bn | $35.08bn | $29.04bn | $25.34bn | $26.68bn | $25.81bn |
| Cash and short-term investments | $4.20bn | $2.22bn | $4.69bn | $5.06bn | $3.39bn | $4.67bn | $4.05bn | $2.34bn | $4.04bn | $3.88bn |
| Total liabilities | $31.01bn | $29.87bn | $30.57bn | $28.36bn | $28.64bn | $21.35bn | $17.01bn | $15.18bn | $16.84bn | $15.13bn |
| Debt | $12.37bn | $11.72bn | $11.66bn | $11.42bn | $12.82bn | $6.98bn | $5.89bn | $6.24bn | $5.06bn | $4.30bn |
| Shareholders' equity | $17.66bn | $16.38bn | $16.26bn | $15.31bn | $16.08bn | $13.73bn | $12.04bn | $10.16bn | $9.84bn | $10.69bn |
| Shares outstanding | 120m | 121m | 122m | 126m | 129m | 132m | 133m | 138m | 142m | 150m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $921.0m | $2.97bn | $3.98bn | $4.59bn | $2.26bn | $5.64bn | $5.28bn | $2.17bn | $4.05bn | $1.94bn |
| Capital spending | −$546.0m | −$575.0m | −$1.00bn | −$1.12bn | −$1.32bn | −$964.0m | −$736.0m | −$612.0m | −$526.0m | −$527.0m |
| Free cash flow | $375.0m | $2.39bn | $2.98bn | $3.47bn | $946.0m | $4.67bn | $4.55bn | $1.56bn | $3.52bn | $1.41bn |
| Dividends paid | −$430.0m | −$431.0m | −$431.0m | −$392.0m | −$354.0m | −$323.0m | −$291.0m | −$265.0m | −$220.0m | −$177.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87bn | $39.65bn | $32.52bn | $32.65bn | $32.39bn | $32.11bn | $29.21bn | $29.40bn |
| Gross profit | $5.50bn | $5.94bn | $3.79bn | $4.66bn | $4.82bn | $5.58bn | $3.83bn | $4.28bn |
| Operating income | $1.56bn | $1.58bn | −$1.02bn | $108.0m | $722.0m | $1.65bn | −$899.0m | $635.0m |
| Net income | $693.0m | $1.19bn | −$796.0m | $195.0m | $545.0m | $1.24bn | −$693.0m | $480.0m |
| Diluted earnings per share | 5.73 | 9.81 | -6.61 | 1.62 | 4.53 | 10.34 | -5.74 | 3.97 |
| Cash from operations | −$426.0m | $1.25bn | −$1.65bn | $971.0m | $1.27bn | $331.0m | −$528.0m | $1.86bn |
| Capital spending | −$132.0m | −$121.0m | −$202.0m | −$135.0m | −$114.0m | −$95.0m | −$154.0m | −$130.0m |
| Free cash flow | −$558.0m | $1.13bn | −$1.85bn | $836.0m | $1.16bn | $236.0m | −$682.0m | $1.73bn |
| Total assets | $57.20bn | $55.28bn | $48.75bn | $49.72bn | $50.36bn | $50.93bn | $46.31bn | $50.01bn |
| Cash and short-term investments | $23.87bn | $21.96bn | $4.20bn | $5.39bn | $4.04bn | $4.25bn | $2.22bn | $5.12bn |
| Debt | $14.25bn | $13.99bn | $12.52bn | $12.61bn | $12.59bn | $13.31bn | $11.87bn | $13.02bn |
| Shareholders' equity | $19.21bn | $18.58bn | $17.66bn | $18.52bn | $18.23bn | $17.75bn | $16.38bn | $17.57bn |
Financial ratios
Data as of 25 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 14.5% | 14.6% | 17.0% | 18.5% | 17.3% | 20.3% |
| Operating margin | 2.5% | 2.0% | 3.6% | 4.3% | 4.4% | 6.4% |
| Net margin | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% |
| Return on equity | 6.7% | 7.4% | 15.3% | 18.3% | 18.2% | 24.5% |
| Return on assets | 2.4% | 2.6% | 5.3% | 6.4% | 6.6% | 9.6% |
| Free cash flow yield | 3.2% | 7.7% | 10.7% | 11.9% | 7.3% | 13.1% |
| Revenue growth | 10.1% | 10.7% | 14.5% | 11.1% | 8.4% | 18.9% |
| Earnings growth | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | 24.4% |
| Current ratio | 0.72x | 0.44x | 0.56x | 0.58x | 0.50x | 0.65x |
| Debt to equity | 0.71x | 0.72x | 0.73x | 0.74x | 0.79x | 0.49x |
| Equity ratio | 36.2% | 35.4% | 34.7% | 35.0% | 35.9% | 39.1% |
| Interest coverage | 5.12x | 3.61x | 7.86x | 9.89x | 11.29x | 17.52x |
| Buybacks as a share of market value | 0.4% | 1.4% | 2.5% | 2.3% | 2.6% | 0.9% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 11.7% | 10.9% | 9.1% |
| Operating income | -3.2% | -8.2% | 3.3% |
| Net income | -24.9% | -18.8% | -0.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 14.5% | 16.0% | 16.7% | 16.4% |
| Operating margin | 2.3% | 2.9% | 3.6% | 3.5% |
| Net margin | 1.0% | 1.7% | 2.3% | 2.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 25.9 | 25.4 | 22.5 | 22.9 | 20.3 | 16.1 | 18.1 | 23.4 | 14.4 | 49.7 |
| Price to sales | 0.2 | 0.3 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 |
Market value over time
31 Oct 2016 to 24 Sept 2026, in USD
$25.88bn$45.98bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 9% | -48% | -8% | 12% | 16% | 5% | 33% | 13% | 22% | 11% |
Dividends and splits
Per share, in the currency the company pays
Paid for 15 years. Last went ex-dividend on 30 Oct 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 2.655 | 3.54 | 3.54 | 3.54 | 3.15 | 2.80 | 2.50 | 2.20 |
- 3-for-2 split · 1 Aug 1991
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.